Guardian Pharmacy officer proposes $989K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Guardian Pharmacy Services, Inc. (GRDN) officer David Martin reported a proposed sale of 20,000 common shares, with an aggregate market value of $988,600 and an approximate sale date of November 17, 2026. The shares were acquired from the issuer via M&A on September 26, 2024.
Key Figures
Key Terms
Rule 10b5-1 regulatory
M&A financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What date does the GRDN notice list for David Martin’s Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.